Literature DB >> 28451629

Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence.

Catherine M Cahill1,2, Anna Mw Taylor3.   

Abstract

Chronic pain is a disease that encompasses both sensory and emotional elements. Opioids are highly effective analgesics because they target both of these elements, by inhibiting pain pathways and alleviating negative affect (including depression) by engaging reward or hedonic pathways. Unfortunately, chronic opioid use is limited by the development of unwanted side effects, such as tolerance, hyperalgesia, and abuse liability. Thus, the challenge of providing effective pain treatment while minimizing these unwanted side effects is an ongoing issue with significant clinical and societal impact. In this review, we posit that neuroinflammation within the central nervous system is a shared phenomenon between chronic pain and opioids that contributes to pain sensitization and negative affect. The implications for pain progression, addiction liability, and alternative treatment strategies are discussed.

Entities:  

Year:  2017        PMID: 28451629      PMCID: PMC5404697          DOI: 10.1016/j.cobeha.2016.12.003

Source DB:  PubMed          Journal:  Curr Opin Behav Sci        ISSN: 2352-1546


  66 in total

1.  Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Yun-Gang Lu; Zhizhong Z Pan
Journal:  Neuropsychopharmacology       Date:  2014-04-01       Impact factor: 7.853

2.  Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.

Authors:  Christopher P Ford; Gregory P Mark; John T Williams
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

3.  Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Wakako Fujita; Howard L Fields
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

4.  High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.

Authors:  Benedikt Fischer; Wayne Jones; Jürgen Rehm
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-14       Impact factor: 2.890

5.  The influence of prescription opioid use duration and dose on development of treatment resistant depression.

Authors:  Jeffrey F Scherrer; Joanne Salas; Mark D Sullivan; F David Schneider; Kathleen K Bucholz; Thomas Burroughs; Laurel Copeland; Brian Ahmedani; Patrick J Lustman
Journal:  Prev Med       Date:  2016-08-03       Impact factor: 4.018

6.  Association between mental health disorders, problem drug use, and regular prescription opioid use.

Authors:  Mark D Sullivan; Mark J Edlund; Lily Zhang; Jürgen Unützer; Kenneth B Wells
Journal:  Arch Intern Med       Date:  2006-10-23

Review 7.  Migraine and reward system-or is it aversive?

Authors:  Catherine M Cahill; Christopher Cook; Sarah Pickens
Journal:  Curr Pain Headache Rep       Date:  2014-05

8.  "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.

Authors:  Adam R Winstock; Nicholas Lintzeris; Toby Lea
Journal:  Int J Drug Policy       Date:  2010-10-16

9.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

10.  Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.

Authors:  Pierre-Eric Lutz; Gulebru Ayranci; Paul Chu-Sin-Chung; Audrey Matifas; Pascale Koebel; Dominique Filliol; Katia Befort; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-05-30       Impact factor: 7.853

View more
  17 in total

1.  Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Authors:  Shiwei Steve Liu; Sarah Pickens; Nicole E Burma; Ines Ibarra-Lecue; Hongyan Yang; Lihua Xue; Chris Cook; Joshua K Hakimian; Amie L Severino; Lindsay Lueptow; Kristina Komarek; Anna M W Taylor; Mary C Olmstead; F Ivy Carroll; Caroline E Bass; Anne M Andrews; Wendy Walwyn; Tuan Trang; Christopher J Evans; Frances M Leslie; Catherine M Cahill
Journal:  J Neurosci       Date:  2019-03-12       Impact factor: 6.167

2.  Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats.

Authors:  Andrew D Gaulden; Nicole Burson; Nareen Sadik; Ishita Ghosh; Sabrina J Khan; Susanne Brummelte; Srinivasu Kallakuri; Shane A Perrine
Journal:  Drug Alcohol Depend       Date:  2021-09-24       Impact factor: 4.852

3.  The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.

Authors:  Kevin Lee; Helen E Vuong; David J Nusbaum; Elaine Y Hsiao; Christopher J Evans; Anna M W Taylor
Journal:  Neuropsychopharmacology       Date:  2018-09-10       Impact factor: 7.853

4.  Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics.

Authors:  Riley D Kirk; Kassie Picard; Joseph A Christian; Shelby L Johnson; Brenton DeBoef; Matthew J Bertin
Journal:  ACS Chem Neurosci       Date:  2020-12-07       Impact factor: 4.418

5.  Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Authors:  Catherine M Cahill; Lindsay Lueptow; Hannah Kim; Raj Shusharla; Amy Bishop; Christopher J Evans
Journal:  Handb Exp Pharmacol       Date:  2022

Review 6.  Reward Circuitry Plasticity in Pain Perception and Modulation.

Authors:  Marcos F DosSantos; Brenda de Souza Moura; Alexandre F DaSilva
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

Review 7.  An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain.

Authors:  Diana I Lurie
Journal:  J Exp Neurosci       Date:  2018-08-13

8.  The Contribution of the Descending Pain Modulatory Pathway in Opioid Tolerance.

Authors:  Lindsay M Lueptow; Amanda K Fakira; Erin N Bobeck
Journal:  Front Neurosci       Date:  2018-11-27       Impact factor: 4.677

Review 9.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

10.  Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder.

Authors:  Wenfei Huang; Erika P Penaherrera; Danaika F Desir; Dominick L Gamarro; Jessica Cottrell; Tinchun Chu; Sulie L Chang
Journal:  J Drug Alcohol Res       Date:  2019-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.